Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Optruma
(raloxifene)
Uses, side effects, dosage information & price range
About this medicine
Optruma is indicated for the treatment and prevention of osteoporosis in post-menopausal women. A significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated. When determining the choice of Optruma or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits (see section 5.1).
Common Brand Names for this Composition
The following popular commercial brand names contain raloxifene as their active ingredient composition:
FIONA 60 MG TABLET
Dr Reddy's Laboratories Ltd
Optruma
Eli Lilly Nederland B.V.
Evista
Substipharm
Raloxifene Teva
Teva B.V.
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
raloxifene
Category
Sex hormones and modulators of the genital system
Manufacturer
Eli Lilly Nederland B.V.
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.